De Moraes C Gustavo, Murphy James T, Kaplan Chad M, Reimann Jeremy J, Skaat Alon, Blumberg Dana M, Al-Aswad Lama, Cioffi George A, Girkin Christopher A, Medeiros Felipe A, Weinreb Robert N, Zangwill Linda, Liebmann Jeffrey M
Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York.
Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
JAMA Ophthalmol. 2017 Jun 1;135(6):617-623. doi: 10.1001/jamaophthalmol.2017.1082.
β-zone parapapillary atrophy (βPPA) has been reported as a risk factor for glaucoma onset and progression. Previous studies have shown that the prevalence of βPPA differs between individuals of African descent (AD) and European descent (ED).
To test whether the association between the presence and progression of βPPA vs visual field progression of glaucoma differs between these 2 ancestry groups.
DESIGN, SETTING, AND PARTICIPANTS: In a prospective, multicenter, longitudinal cohort study, 634 individuals (1090 eyes) enrolled in the African Descent and Evaluation Study (ADAGES) with a diagnosis of glaucomatous optic neuropathy (GON) or ocular hypertension (OHT) and at least 2 disc stereophotographs were included. Two graders masked to clinical and ancestry data reviewed and graded the baseline and last disc stereophotographs for the presence of βPPA at baseline and βPPA progression (development or enlargement). Mixed-effects linear models were tested with visual field mean deviation as a dependent variable and time (alone and with interaction terms) as independent variables. ADAGES enrollment began in January 2003 and ended in July 2006; follow-up ended in 2016.
Disc stereophotographs.
Progression of βPPA in AD and ED individuals.
In 634 patients, a total of 814 eyes of AD (395 eyes) and ED (419) patients with GON and 276 eyes of AD (106) and ED (170) patients with OHT who were enrolled in ADAGES were analyzed. There were 336 (53.0%) women in the study; mean (SD) age was 61.9 (12.7) years. In the OHT group, the association between βPPA at baseline and visual field progression was not significantly different between AD and ED eyes (β = 0.071; 95% CI, -0.016 to 0.158; P = .11), nor was the association between βPPA progression and visual field progression (β = 0.020; 95% CI, -0.465 to 0.506; P = .93). In the GON group, ED eyes with baseline βPPA progressed faster than did AD eyes with baseline βPPA (β = -0.124; 95% CI, -0.241 to -0.007; P = .04), although the association between βPPA progression and visual field progression did not differ significantly between race groups (β = -0.101; 95% CI, -0.323 to 0.119; P = .37).
Race had a significant effect on the association between baseline βPPA and rates of visual field progression in eyes with GON. Progression of βPPA was not associated with faster visual field progression in either racial group.
β区视乳头旁萎缩(βPPA)已被报道为青光眼发病和进展的一个风险因素。既往研究表明,非洲裔(AD)个体和欧洲裔(ED)个体中βPPA的患病率有所不同。
检验在这两个种族群体中,βPPA的存在及进展与青光眼视野进展之间的关联是否存在差异。
设计、地点和参与者:在一项前瞻性、多中心、纵向队列研究中,纳入了非洲裔和评估研究(ADAGES)中的634名个体(1090只眼),这些个体被诊断为青光眼性视神经病变(GON)或高眼压症(OHT),且至少有2张视盘立体照片。两名对临床和种族数据不知情的分级人员对基线和最后一张视盘立体照片进行审查,并对基线时βPPA的存在情况以及βPPA进展(发生或扩大)进行分级。以视野平均偏差作为因变量,时间(单独及与交互项)作为自变量,对混合效应线性模型进行检验。ADAGES于2003年1月开始入组,2006年7月结束;随访于2016年结束。
视盘立体照片。
AD和ED个体中βPPA的进展情况。
在634例患者中,对ADAGES研究中纳入的814只GON患者的眼睛(AD患者395只眼,ED患者419只眼)以及276只OHT患者的眼睛(AD患者106只眼,ED患者170只眼)进行了分析。研究中有336名(53.0%)女性;平均(标准差)年龄为61.9(12.7)岁。在OHT组中,AD和ED眼睛在基线时βPPA与视野进展之间的关联无显著差异(β = 0.071;95%CI,-0.016至0.158;P = 0.11),βPPA进展与视野进展之间的关联也无显著差异(β = 0.020;95%CI,-0.465至0.506;P = 0.93)。在GON组中,基线时有βPPA的ED眼睛比基线时有βPPA的AD眼睛进展更快(β = -0.124;95%CI,-0.241至-0.007;P = 0.04),尽管种族组之间βPPA进展与视野进展之间的关联无显著差异(β = -0.101;95%CI,-0.323至0.119;P = 0.37)。
种族对GON患者眼睛中基线βPPA与视野进展速率之间的关联有显著影响。在两个种族组中,βPPA进展均与更快的视野进展无关。